Standard Methotrexate Dosing Basics
Methotrexate dosing varies by condition—typically low weekly doses (7.5-25 mg) for rheumatoid arthritis (RA) or psoriasis, higher for cancer (up to 12 g/m² IV weekly or pulsed). Adjustments prioritize renal function, as methotrexate is primarily excreted by kidneys; age often correlates with declining glomerular filtration rate (GFR).[1][2]
How Age Impacts Dosing Adjustments
Older adults (over 65) require lower starting doses and closer monitoring due to reduced renal clearance, higher toxicity risk, and comorbidities. For RA, guidelines recommend starting at 7.5 mg/week in patients ≥75 years, titrating slowly to ≤15-20 mg/week max, versus 15-25 mg/week in younger adults. In oncology, elderly patients get 50-75% dose reductions if GFR <60 mL/min, common in those over 70.[3][4]
Renal function trumps age alone—use Cockcroft-Gault formula for creatinine clearance:
- GFR >80 mL/min: Full dose.
- GFR 50-80 mL/min: 25-50% reduction.
- GFR <50 mL/min: Avoid or use alternative; high-dose regimens contraindicated below 60 mL/min.[2][5]
Why Age Increases Toxicity Risk
Pharmacokinetics shift with age: decreased tubular secretion raises serum levels, prolonging exposure. Elderly patients face 2-5x higher rates of severe myelosuppression, mucositis, and hepatotoxicity. Polypharmacy (e.g., NSAIDs, diuretics) exacerbates this via competition for renal excretion.[1][4]
Monitoring and Adjustments in Practice
- Baseline: Check GFR, CBC, liver enzymes, folate levels before starting.
- Ongoing: Weekly labs first month, then monthly; hold if GFR drops 20-30%.
- Elderly-specific: Supplement folic acid (1-5 mg/day) routinely; consider subcutaneous over oral for better absorption.[3][6]
Differences by Condition
| Condition | Younger Adult Dosing | Elderly Adjustment (>65-75 years) |
|-----------|----------------------|-----------------------------------|
| RA/Psoriasis | 15-25 mg/week PO/IM | Start 7.5-10 mg/week; cap at 15 mg; halve if GFR <60 mL/min [3] |
| Acute Lymphoblastic Leukemia | 3-5 g/m² IV | 50% reduction if GFR 30-60; avoid if <30 [2] |
| Osteosarcoma | 12 g/m² IV | Monitor leucovorin rescue closely; dose reduce 25-50% [5] |
When to Avoid or Switch Therapies
Contraindicated in elderly with GFR <30-50 mL/min, active infection, or alcohol use. Alternatives include biologics (e.g., TNF inhibitors) for RA if toxicity emerges.[4][6]
[1] American College of Rheumatology RA Guidelines (2021)
[2] Lexicomp: Methotrexate Monograph
[3] British Society for Rheumatology Guidelines (2017)
[4] NCCN Cancer Drugs Compendium: Methotrexate
[5] FDA Label: Methotrexate (updated 2023)
[6] ASHP Guidelines on High-Dose Methotrexate